Celacade
Celacade
Celacade (pronounced: /sɛləkeɪd/) is a medical treatment developed by Vasogen Inc. It is designed to modulate the immune system and is used in the treatment of chronic heart failure and peripheral artery disease.
Etymology
The term "Celacade" is a proprietary name and its etymology is not publicly disclosed. It is likely derived from the words "cell" and "cascade", referring to the treatment's mechanism of action on the body's cells.
Mechanism of Action
Celacade works by modulating the immune system. It involves the extraction of a small amount of the patient's blood, which is then treated with ozone and ultraviolet light. This process is believed to induce a controlled oxidative stress, which when re-infused into the patient, triggers an immune response that leads to anti-inflammatory effects.
Related Terms
- Chronic Heart Failure: A condition where the heart is unable to pump enough blood to meet the body's needs. Celacade is used as a treatment for this condition.
- Peripheral Artery Disease: A circulatory condition in which narrowed blood vessels reduce blood flow to the limbs. Celacade is also used in the treatment of this disease.
- Vasogen Inc: The company that developed Celacade.
- Ozone Therapy: A form of alternative medicine treatment that purports to increase the amount of oxygen in the body through the introduction of ozone. This is similar to the process used in Celacade treatment.
- Ultraviolet Light Therapy: A treatment used in dermatology that uses UV light to treat skin conditions. This is also similar to the process used in Celacade treatment.
External links
- Medical encyclopedia article on Celacade
- Wikipedia's article - Celacade
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski